Researchers use endoscope to deliver gene therapy in animal study

October 2, 2018 by Patrick Smith, Johns Hopkins University School of Medicine
These pig liver tissue samples show the expression of proteins AKT and Beta-catenin two months after researchers administered gene therapy to the animal via ERCP. A team of Johns Hopkins researchers published an article this summer on using the endoscopic technique to deliver engineered genes to the liver through the common bile duct. Credit: Johns Hopkins Medicine

Fixing or replacing faulty genes has emerged as a key to unlocking cures for numerous devastating diseases. But if the new, engineered genes can't find their way into the patient's genomic sequence, they won't help.

Johns Hopkins gastroenterologists Florin Selaru and Vivek Kumbhari believe they've taken a major step in the direction of helping patients with certain liver disorders by using an increasingly common endoscopic procedure to deliver therapeutic genes to the liver via the common bile duct. And they believe their novel method is safe and effective enough that are not far off.

Selaru and Kumbhari published an article this summer in the journal Gastrointestinal Endoscopy that describes a study they performed in a dozen pigs. In the study, the researchers introduced therapeutic genes to the liver by accessing the using an endoscopic technique most commonly used to diagnose and treat problems in the gallbladder, biliary system, pancreas and liver.

The researchers employed the technique, called endoscopic retrograde cholangiopancreatography (ERCP), to safely and successfully implant a human version of genes into cells in the pigs' livers. The engineered genes expressed the intended proteins in all 12 of the animals 21, 30 and 60 days from the time of the procedures.

"We're pleased with these results, and we believe there's a great future for ERCP to deliver ," says Selaru.

The current standard for administering non-viral based gene therapy is via intravascular injection, which requires a larger volume and presents cardiorespiratory risks.

"In our study, we saw none of the side effects that accompany the intravascular injections," Kumbhari says. "There was no biliary or liver injury. Our results indicate that gene therapy via ERCP is much less invasive than injection. It's technically simpler and safer."

The researchers said pigs provided the closest simulation to human patients, given the physiological and genetic similarities.

ERCP uses a flexible endoscope to access the common bile duct, located between the liver and the pancreas. The endoscopist inserts the scope into the mouth of an anesthetized patient and guides the device down the esophagus, into the stomach and then to the duodenum. A smaller device emerges from the end of the scope and is guided by the endoscopist into the bile ducts. The procedure makes use of both a camera on the endoscope and X-ray technology to observe the bile ducts and, in this case, guide the injection of therapeutic genes into liver cells.

Engineering new versions of mutated or otherwise malfunctioning single genes has led to important new therapies and discoveries in recent years. But thus far, patients with hereditary monogenic diseases such as hemophilia, cystic fibrosis and Wilson's disease have seen few benefits from gene therapy, as medicine has lacked a safe and effective way to transport engineered genes to their systems. The gene must be administered, must reach its intended targets, must get into the faulty or damaged cells and then either disrupt or express a protein.

"Until now, it hasn't been possible to perform -specific hydrodynamic gene delivery in a large animal model with direct translatability to human trials," says Selaru.

"The technique was cumbersome, technically challenging and invasive," Kumbhari adds. "There was very little progress in the direction of clinical trials."

Among the challenges of venous injection of therapeutic genes has been the need for a high volume of the solution that contains the engineered DNA molecules. Pushing that solution rapidly into a vein has led to ruptures and other vein injuries. On top of that, the DNA frequently missed its target and failed to replicate successfully.

The Johns Hopkins researchers found, however, that injection into the bile ducts required a smaller volume and led to no organ injury. And best of all, the replicated and expressed their proteins.

"Of course, at this point, we can only hypothesize that this procedure will be equally benign in humans as it has been in our work with pigs," says Kumbhari. "But it appears that safety shouldn't be a barrier to clinical trials."

Explore further: Liver study offers insights into hard-to-treat diseases

Related Stories

Liver study offers insights into hard-to-treat diseases

March 9, 2018
A key cell process that could cause damage to bile ducts and help explain some liver diseases has been identified by scientists.

Artificial bile ducts grown in lab, transplanted into mice could help treat liver disease

July 3, 2017
Cambridge scientists have developed a new method for growing and transplanting artificial bile ducts that could in future be used to help treat liver disease in children, reducing the need for liver transplantation.

Fewer ERCPs needed to treat benign biliary obstructions with use of self-expandable stents

March 28, 2016
Placement of a single covered, self-expanding metallic stent (cSEMS) via endoscopic retrograde cholangiopancreatography (ERCP) resolved benign obstructions of the pancreatic and biliary ducts as well as placement of multiple ...

Cystic fibrosis treatment tested on lab-grown bile ducts

July 14, 2015
An experimental cystic fibrosis drug has been shown prevent the disease's damage to the liver, thanks to a world-first where scientists grew mini bile ducts in the lab.

Scientists create most sophisticated human liver model yet

February 13, 2018
Scientists at Wake Forest Institute for Regenerative Medicine (WFIRM) have developed the most sophisticated mini-livers to date. These organoids can potentially help scientists better understand certain congenital liver diseases ...

New imaging method makes gall bladder removals, other procedures more safe

March 10, 2016
UCLA researchers have discovered an optimal way to image the bile ducts during gallbladder removal surgeries using a tested and safe dye and a real-time near-infrared florescence laparoscopic camera, a finding that will make ...

Recommended for you

Targeting a hunger hormone to treat obesity

October 22, 2018
About 64 per cent of Canadian adults are overweight or obese, according to Health Canada. That's a problem, because obesity promotes the emergence of chronic diseases such as type 2 diabetes, heart disease and some cancers.

Scientists in Sweden may have figured out one way acne bacteria defies treatment

October 22, 2018
Researchers in Sweden have discovered how acne-causing bacteria feed off their human hosts. The study, which was performed at KTH Royal Institute of Technology, could make it possible to find effective ways to treat severe ...

Gene plays critical role in noise-induced deafness

October 19, 2018
In experiments using mice, a team of UC San Francisco researchers has discovered a gene that plays an essential role in noise-induced deafness. Remarkably, by administering an experimental chemical—identified in a separate ...

Scientists grow functioning human neural networks in 3-D from stem cells

October 18, 2018
A team of Tufts University-led researchers has developed three-dimensional (3-D) human tissue culture models for the central nervous system that mimic structural and functional features of the brain and demonstrate neural ...

Functional engineered oesophagus could pave way for clinical trials 

October 18, 2018
The world's first functional oesophagus engineered from stem cells has been grown and successfully transplanted into mice, as part of a pioneering new study led by UCL.

New findings cast light on lymphatic system, key player in human health

October 16, 2018
Scientists at the Oklahoma Medical Research Foundation have broken new ground in understanding how the lymphatic system works, potentially opening the door for future therapies.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.